Skip to main content
Clinical Trials/NL-OMON43353
NL-OMON43353
Completed
N/A

A prospective study on the cardio-metabolic effects of apremilast in patients with psoriatic arthritis - Aprmilast for psoriatic arthritis

Reade0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
inflammatory arthritis
Sponsor
Reade
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Reade

Eligibility Criteria

Inclusion Criteria

  • \- Adult (\>\=18 years) patients with active psoriatic arthritis
  • \- Starting apremilast

Exclusion Criteria

  • \- Inability or unwillingness to sign informed consent
  • \- Contraindication for apremilast (i.e. pregnancy and hypersensitivity to apremilast and/or its excipients)

Outcomes

Primary Outcomes

Not specified

Similar Trials